prednisolone has been researched along with Cancer of Esophagus in 28 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effectiveness of oral prednisolone in controlling postprocedure esophageal stricture." | 7.77 | Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Nishiyama, H; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011) |
| "Oral prednisolone was started with 0." | 5.37 | Effect of oral prednisolone on esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a case report. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011) |
| " Those who received intralesional triamcinolone injection combined with oral prednisolone administration were assigned to the treatment group, while those who were treated without any prophylaxis of esophageal stricture were assigned to the control group." | 3.91 | Long-term efficacy and safety of intralesional steroid injection plus oral steroid administration in preventing stricture after endoscopic submucosal dissection for esophageal epithelial neoplasms. ( Chen, T; Chen, W; Chu, Y; Li, H; Xu, M; Yao, L; Zhang, Y; Zhong, Y; Zhou, P, 2019) |
| "To evaluate the effectiveness of oral prednisolone in controlling postprocedure esophageal stricture." | 3.77 | Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Nishiyama, H; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011) |
| "Use of oral prednisolone administration may be an effective treatment strategy for reducing post-ESD esophageal stricture after complete circular ESD." | 3.77 | Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Nishiyama, H; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011) |
| "Dermatomyositis is a multisystem disease manifesting as an idiopathic inflammatory myopathy, characterised predominantly by cutaneous and muscular abnormalities." | 1.48 | Dermatomyositis as a paraneoplastic phenomenon in oesophageal cancer. ( Laidler, NK, 2018) |
| "Oral prednisolone was administered to the study group at a dose of 30 mg/day on the third day post-ESD, and then tapered gradually (30, 25, 20, 15, 10, and 5 mg for 14 days)." | 1.46 | Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. ( Cai, J; Gong, W; Su, L; Tang, X; Yuan, F; Zhang, Y; Zhou, G, 2017) |
| "There has been no recurrence of esophageal cancer or relapse of nephrotic syndrome during a period of 18 months after esophagectomy." | 1.39 | Patient with esophageal cancer showing remission of nephrotic syndrome after esophagectomy: report of a case. ( Iida, M; Ito, H; Kawano, T; Kumagai, Y; Odajima, H; Yamazaki, S, 2013) |
| "We describe a patient with inoperable oesophageal cancer who had unexplained mental confusion for three days due to an unobserved corticosteroid-induced hyperglycaemic hyperosmolar syndrome." | 1.39 | [In-hospital cardiac arrest due to unobserved steroid-induced hyperglycaemic hyperosmolar syndrome]. ( Brandt, B; Jensen, K; Steinthorsdottir, KJ, 2013) |
| "We report a case of acquired hemophilia A (AHA) after esophageal resection." | 1.39 | Acquired hemophilia A caused by factor VIII inhibitors: report of a case. ( Hosoya, Y; Lefor, A; Madoiwa, S; Matsumoto, S; Matsumura, M; Nunomiya, S; Sata, N; Yasuda, Y; Zuiki, T, 2013) |
| "Medical history revealed dysphagia during the past 6 months and further evaluation brought to light a squamous cell carcinoma (SCC) in the esophagus." | 1.39 | Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma. ( Ahmadinejad, M; Minoo, A; Nader, R; Roushan, N, 2013) |
| "Oral prednisolone was started with 0." | 1.37 | Effect of oral prednisolone on esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a case report. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011) |
| "Endoscopic examination revealed esophageal cancer." | 1.29 | [Chronic myelomonocytic leukemia and esophageal cancer developed in a renal allograft recipient]. ( Fujita, N; Goto, H; Inaba, T; Itoh, K; Misawa, S; Murakami, S; Nakagawa, M; Oku, N; Shima, T; Shimazaki, C, 1993) |
| "Prednisolone could cause dramatic increase in activity of ALP, but no change in ALP isozyme spectrum and concomitant increase in lactic dehydrogenase activity were found after prednisolone treatment." | 1.29 | [Expression of placental alkaline phosphatase in esophageal cancer cell line Eca109]. ( Yan, X; Zhang, F; Zhang, M, 1996) |
| "Domperidone was given twice a day for one week." | 1.27 | [Effect of combined use of adrenocortical hormones and domperidone as anti-emetics during cisplatin therapy]. ( Hirose, Y; Matsushita, T; Mise, K; Nakanishi, M; Shirosaki, H; Tanaka, T; Yamaoto, T, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 4 (14.29) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 18 (64.29) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kaviani, A | 1 |
| Khansari Nejad, N | 1 |
| Akour, A | 1 |
| AlMuhaissen, SA | 1 |
| Nusair, MB | 1 |
| Al-Tammemi, AB | 1 |
| Mahmoud, NN | 1 |
| Jalouqa, S | 1 |
| Alrawashdeh, MN | 1 |
| Shanahan, JP | 1 |
| Moore, CM | 1 |
| Kampf, JW | 1 |
| Szymczak, NK | 1 |
| Guo, J | 1 |
| Wang, H | 1 |
| Luo, Y | 1 |
| An, H | 1 |
| Zhang, Z | 2 |
| Liu, G | 1 |
| Li, J | 1 |
| Metcalfe, GD | 1 |
| Smith, TW | 1 |
| Hippler, M | 1 |
| Ayala Izurieta, JE | 1 |
| Márquez, CO | 1 |
| García, VJ | 1 |
| Jara Santillán, CA | 1 |
| Sisti, JM | 1 |
| Pasqualotto, N | 1 |
| Van Wittenberghe, S | 1 |
| Delegido, J | 1 |
| Kubo, Y | 1 |
| Kitagawa, Y | 1 |
| Miyazaki, T | 1 |
| Sohda, M | 1 |
| Yamaji, T | 1 |
| Sakai, M | 1 |
| Saeki, H | 1 |
| Nemoto, K | 1 |
| Oyama, T | 2 |
| Muto, M | 1 |
| Takeuchi, H | 1 |
| Toh, Y | 1 |
| Matsubara, H | 1 |
| Mano, M | 1 |
| Kono, K | 1 |
| Kato, K | 1 |
| Yoshida, M | 1 |
| Kawakubo, H | 1 |
| Booka, E | 1 |
| Yamatsuji, T | 1 |
| Kato, H | 1 |
| Ito, Y | 1 |
| Ishikawa, H | 1 |
| Ishihara, R | 1 |
| Tsushima, T | 1 |
| Kawachi, H | 1 |
| Kojima, T | 1 |
| Kuribayashi, S | 1 |
| Makino, T | 1 |
| Matsuda, S | 1 |
| Doki, Y | 1 |
| Ma, P | 1 |
| Tang, X | 2 |
| Zhang, L | 2 |
| Wang, X | 1 |
| Wang, W | 1 |
| Zhang, X | 1 |
| Wang, S | 2 |
| Zhou, N | 1 |
| Dodd, J | 1 |
| Jordan, R | 1 |
| Makhlina, M | 1 |
| Pesco Koplowitz, L | 1 |
| Koplowitz, B | 1 |
| Barnett, K | 1 |
| Yang, WH | 1 |
| Spana, C | 1 |
| Buchanan, SW | 1 |
| Mafa-Attoye, T | 1 |
| Dunfield, K | 1 |
| Thevathasan, NV | 1 |
| Isaac, ME | 1 |
| Wu, X | 2 |
| Huang, JW | 1 |
| Su, BK | 1 |
| Yuan, L | 1 |
| Zheng, WQ | 1 |
| Zhang, H | 2 |
| Zheng, YX | 1 |
| Zhu, W | 1 |
| Chou, PT | 1 |
| Manso, AP | 1 |
| De Morais, DC | 1 |
| Yamamoto, K | 1 |
| Owen, G | 1 |
| de Carvalho, RM | 1 |
| Palma-Dibb, RG | 1 |
| Brown, JC | 1 |
| Yang, S | 1 |
| Mire, EF | 1 |
| Miele, L | 1 |
| Ochoa, A | 1 |
| Zabaleta, J | 1 |
| Katzmarzyk, PT | 1 |
| Moi, CT | 1 |
| Bhowmick, S | 1 |
| Qureshi, M | 1 |
| Wang, K | 1 |
| Feng, B | 1 |
| Yang, Y | 1 |
| Chen, Y | 1 |
| Wang, Y | 2 |
| Yang, L | 1 |
| Jiang, K | 1 |
| James, TD | 1 |
| Chaturvedi, V | 1 |
| Postiglione, WM | 1 |
| Chakraborty, RD | 1 |
| Yu, B | 1 |
| Tabiś, W | 1 |
| Hameed, S | 1 |
| Biniskos, N | 1 |
| Jacobson, A | 1 |
| Zhou, H | 1 |
| Greven, M | 1 |
| Ferry, VE | 1 |
| Leighton, C | 1 |
| Wu, F | 1 |
| Lei, H | 1 |
| Chen, G | 1 |
| Chen, C | 1 |
| Song, Y | 1 |
| Cao, Z | 1 |
| Zhang, C | 2 |
| Zhou, J | 1 |
| Lu, Y | 1 |
| Pappone, C | 1 |
| Santinelli, V | 1 |
| Mecarocci, V | 1 |
| Tondi, L | 1 |
| Ciconte, G | 1 |
| Manguso, F | 1 |
| Sturla, F | 1 |
| Vicedomini, G | 1 |
| Micaglio, E | 1 |
| Anastasia, L | 1 |
| Pica, S | 1 |
| Camporeale, A | 1 |
| Lombardi, M | 1 |
| Shieh, PB | 1 |
| Elfring, G | 1 |
| Trifillis, P | 1 |
| Santos, C | 1 |
| Peltz, SW | 1 |
| Parsons, JA | 1 |
| Apkon, S | 1 |
| Darras, BT | 1 |
| Campbell, C | 1 |
| McDonald, CM | 1 |
| Galaviz, KI | 1 |
| Shah, NS | 1 |
| Gutierrez, M | 1 |
| Collins, LF | 1 |
| Lahiri, CD | 1 |
| Moran, CA | 1 |
| Szabo, B | 1 |
| Sumitani, J | 1 |
| Rhodes, J | 1 |
| Marconi, VC | 1 |
| Nguyen, ML | 1 |
| Cantos, VD | 1 |
| Armstrong, WS | 1 |
| Colasanti, JA | 1 |
| Kadota, T | 1 |
| Yoda, Y | 1 |
| Hori, K | 1 |
| Shinmura, K | 1 |
| Oono, Y | 1 |
| Ikematsu, H | 1 |
| Yano, T | 1 |
| Zhou, G | 1 |
| Yuan, F | 1 |
| Cai, J | 1 |
| Gong, W | 1 |
| Su, L | 1 |
| Zhang, Y | 2 |
| Iizuka, T | 1 |
| Kikuchi, D | 1 |
| Hoteya, S | 1 |
| Kaise, M | 1 |
| Chu, Y | 1 |
| Chen, T | 1 |
| Li, H | 1 |
| Zhou, P | 1 |
| Chen, W | 1 |
| Zhong, Y | 1 |
| Yao, L | 1 |
| Xu, M | 1 |
| Laidler, NK | 1 |
| Sato, H | 1 |
| Inoue, H | 1 |
| Kobayashi, Y | 1 |
| Maselli, R | 1 |
| Santi, EG | 1 |
| Hayee, B | 1 |
| Igarashi, K | 1 |
| Yoshida, A | 1 |
| Ikeda, H | 1 |
| Onimaru, M | 1 |
| Aoyagi, Y | 1 |
| Kudo, SE | 1 |
| Ito, H | 1 |
| Kumagai, Y | 1 |
| Iida, M | 1 |
| Yamazaki, S | 1 |
| Odajima, H | 1 |
| Kawano, T | 1 |
| Jensen, K | 1 |
| Steinthorsdottir, KJ | 1 |
| Brandt, B | 1 |
| Ishida, T | 1 |
| Morita, Y | 1 |
| Hoshi, N | 1 |
| Yoshizaki, T | 1 |
| Ohara, Y | 1 |
| Kawara, F | 1 |
| Tanaka, S | 1 |
| Yamamoto, Y | 1 |
| Matsuo, H | 1 |
| Iwata, K | 1 |
| Toyonaga, T | 1 |
| Azuma, T | 1 |
| Ito, M | 1 |
| Matsumoto, S | 2 |
| Takayama, T | 1 |
| Wakatsuki, K | 1 |
| Tanaka, T | 2 |
| Migita, K | 1 |
| Nakajima, Y | 1 |
| Yu, JP | 1 |
| Liu, YJ | 1 |
| Tao, YL | 1 |
| Ruan, RW | 1 |
| Cui, Z | 1 |
| Zhu, SW | 1 |
| Shi, W | 1 |
| Mihara, K | 1 |
| Sasaki, N | 1 |
| Mamoru, O | 1 |
| Kanbe, M | 1 |
| Ichinohe, T | 1 |
| Suehiro, S | 1 |
| Nakashima, H | 1 |
| Fujimoto, M | 1 |
| Watanabe, R | 1 |
| Ishiura, N | 1 |
| Yamamoto, AI | 1 |
| Hashimoto, T | 1 |
| Tamaki, K | 1 |
| Yamaguchi, N | 3 |
| Isomoto, H | 3 |
| Shikuwa, S | 3 |
| Nakayama, T | 3 |
| Hayashi, T | 3 |
| Ohnita, K | 3 |
| Takeshima, F | 3 |
| Kohno, S | 3 |
| Nakao, K | 3 |
| Nishiyama, H | 2 |
| Sawada, T | 1 |
| Adachi, Y | 1 |
| Ishii, Y | 1 |
| Yasui, H | 1 |
| Arimura, Y | 1 |
| Endo, T | 1 |
| Hosoya, Y | 1 |
| Matsumura, M | 1 |
| Madoiwa, S | 1 |
| Zuiki, T | 1 |
| Nunomiya, S | 1 |
| Lefor, A | 1 |
| Sata, N | 1 |
| Yasuda, Y | 1 |
| Ahmadinejad, M | 1 |
| Minoo, A | 1 |
| Roushan, N | 1 |
| Nader, R | 1 |
| Shibuya, Y | 1 |
| Matuo, K | 1 |
| Kawada, T | 1 |
| Kosugi, T | 1 |
| Gomi, T | 1 |
| Takahashi, O | 1 |
| Okushiba, S | 1 |
| Kondo, S | 1 |
| Morikawa, T | 1 |
| Hirano, S | 1 |
| Miyamoto, M | 1 |
| Shichinohe, T | 1 |
| Hara, T | 1 |
| Kawarada, Y | 1 |
| Saito, K | 1 |
| Takeuchi, M | 1 |
| Shima, T | 1 |
| Oku, N | 1 |
| Goto, H | 1 |
| Inaba, T | 1 |
| Murakami, S | 1 |
| Itoh, K | 1 |
| Fujita, N | 1 |
| Shimazaki, C | 1 |
| Misawa, S | 1 |
| Nakagawa, M | 1 |
| Gupta, NM | 1 |
| Goenka, MK | 1 |
| Jindal, A | 1 |
| Behera, A | 1 |
| Vaiphei, K | 1 |
| Ramesh, V | 1 |
| Tanwar, RK | 1 |
| Kaushal, R | 1 |
| Rath, GK | 1 |
| Vaid, A | 1 |
| Pathak, V | 1 |
| Choubey, RP | 1 |
| Zhang, M | 1 |
| Yan, X | 1 |
| Zhang, F | 1 |
| Beĭbutov, ShM | 1 |
| Isaev, IG | 1 |
| Nakanishi, M | 1 |
| Hirose, Y | 1 |
| Mise, K | 1 |
| Matsushita, T | 1 |
| Yamaoto, T | 1 |
| Shirosaki, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Administration of Oral Prednisolone to Prevent Esophageal Stricture After Balloon-type Radiofrequency Ablation for Long-segment Esophageal Neoplasia[NCT05768282] | Phase 4 | 50 participants (Anticipated) | Interventional | 2016-01-01 | Recruiting | ||
| Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery[NCT02703376] | Phase 1 | 8 participants (Anticipated) | Interventional | 2016-01-31 | Recruiting | ||
| Effectiveness Evaluation of Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Early Esophageal Cancer Invading More Than 2/3 Esophageal Perimeter[NCT03165344] | 66 participants (Actual) | Interventional | 2017-02-10 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for prednisolone and Cancer of Esophagus
| Article | Year |
|---|---|
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes | 2021 |
Cronkhite-Canada syndrome associated with esophageal and gastric cancers: report of a case.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Endoscopy, Gastrointestinal; Esop | 2015 |
Prevention of Esophageal Stricture After Endoscopic Submucosal Dissection: A Systematic Review.
Topics: Administration, Oral; Anti-Inflammatory Agents; Dilatation; Dissection; Esophageal Neoplasms; Esopha | 2015 |
[Adult onset Still's disease associated esophageal cancer: a case report].
Topics: Aged; Anti-Inflammatory Agents; Esophageal Neoplasms; Humans; Male; Paraneoplastic Syndromes; Predni | 2003 |
Primary lymphoma of the esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Ad | 1996 |
23 other studies available for prednisolone and Cancer of Esophagus
| Article | Year |
|---|---|
Prophylactic steroid administration against strictures is not enough for mucosal defects involving the entire circumference of the esophageal lumen after esophageal endoscopic submucosal dissection (ESD).
Topics: Aged; Aged, 80 and over; Catheterization; Constriction, Pathologic; Dilatation; Endoscopic Mucosal R | 2020 |
Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Administration, Oral; Aged; Carcinoma, Squamous Cell; Drug Administration Schedule; Endoscopic Mucos | 2017 |
Effectiveness of modified oral steroid administration for preventing esophageal stricture after entire circumferential endoscopic submucosal dissection.
Topics: Administration, Oral; Aged; Aged, 80 and over; Endoscopic Mucosal Resection; Esophageal Neoplasms; E | 2018 |
Long-term efficacy and safety of intralesional steroid injection plus oral steroid administration in preventing stricture after endoscopic submucosal dissection for esophageal epithelial neoplasms.
Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma; Dilatation; Endoscopic Mucosal Resection; | 2019 |
Dermatomyositis as a paraneoplastic phenomenon in oesophageal cancer.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Dermatomyositis; Endoscopic Mucosal Resection | 2018 |
Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone.
Topics: Adenocarcinoma; Administration, Oral; Aged; Carcinoma, Squamous Cell; Cohort Studies; Combined Modal | 2013 |
Patient with esophageal cancer showing remission of nephrotic syndrome after esophagectomy: report of a case.
Topics: Aged; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Esophageal Neoplasms; Esoph | 2013 |
[In-hospital cardiac arrest due to unobserved steroid-induced hyperglycaemic hyperosmolar syndrome].
Topics: Diagnostic Errors; Esophageal Neoplasms; Female; Glucocorticoids; Heart Arrest; Humans; Hyperglycemi | 2013 |
Disseminated nocardiosis during systemic steroid therapy for the prevention of esophageal stricture after endoscopic submucosal dissection.
Topics: Administration, Oral; Aged, 80 and over; Bacteremia; Dissection; Dose-Response Relationship, Drug; D | 2015 |
Solitary plasmablastic lymphoma in the esophagus.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Esophageal Neo | 2016 |
Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
Topics: Aged; Autoantibodies; Carcinoma, Squamous Cell; Dapsone; Desmoglein 1; Desmoglein 3; Desmosomes; Eos | 2010 |
Effect of oral prednisolone on esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a case report.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Dissection; Endoscopy, Gastrointestinal; | 2011 |
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut | 2011 |
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut | 2011 |
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut | 2011 |
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut | 2011 |
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut | 2011 |
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut | 2011 |
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut | 2011 |
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut | 2011 |
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut | 2011 |
Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Topics: Aged; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Dissection; Esophageal Ne | 2011 |
Esophageal lesions in myeloproliferative neoplasms.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Esophageal Neopl | 2012 |
Acquired hemophilia A caused by factor VIII inhibitors: report of a case.
Topics: Aged, 80 and over; Autoantibodies; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Esophage | 2013 |
Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Autoantibodies; Autoimmune Diseases; Carcinoma, Squamous | 2013 |
Esophageal pemphigus vulgaris with carcinoma: postoperative steroid therapy based on pemphigus-related antibodies.
Topics: Aged; Autoantibodies; Carcinoma, Squamous Cell; Desmogleins; Esophageal Neoplasms; Esophagectomy; Hu | 2005 |
[Chronic myelomonocytic leukemia and esophageal cancer developed in a renal allograft recipient].
Topics: Azathioprine; Carcinoma, Squamous Cell; Esophageal Neoplasms; Humans; Immunosuppression Therapy; Kid | 1993 |
Synchronous oesophageal carcinoma with non Hodgkin's lymphoma, problems with management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; | 1996 |
[Expression of placental alkaline phosphatase in esophageal cancer cell line Eca109].
Topics: Alkaline Phosphatase; Antineoplastic Agents, Hormonal; Esophageal Neoplasms; GPI-Linked Proteins; Hu | 1996 |
[Immediate results of polychemotherapy in esophageal cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Demecolcine; Drug Evaluation | 1986 |
[Effect of combined use of adrenocortical hormones and domperidone as anti-emetics during cisplatin therapy].
Topics: Adult; Aged; Breast Neoplasms; Cisplatin; Domperidone; Drug Therapy, Combination; Esophageal Neoplas | 1985 |